Correlation Between Raytheon Technologies and VanEck Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Raytheon Technologies and VanEck Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Raytheon Technologies and VanEck Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Raytheon Technologies and VanEck Biotech ETF, you can compare the effects of market volatilities on Raytheon Technologies and VanEck Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Raytheon Technologies with a short position of VanEck Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Raytheon Technologies and VanEck Biotech.

Diversification Opportunities for Raytheon Technologies and VanEck Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Raytheon and VanEck is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Raytheon Technologies and VanEck Biotech ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Biotech ETF and Raytheon Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Raytheon Technologies are associated (or correlated) with VanEck Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Biotech ETF has no effect on the direction of Raytheon Technologies i.e., Raytheon Technologies and VanEck Biotech go up and down completely randomly.

Pair Corralation between Raytheon Technologies and VanEck Biotech

If you would invest (100.00) in Raytheon Technologies on January 24, 2024 and sell it today you would earn a total of  100.00  from holding Raytheon Technologies or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Raytheon Technologies  vs.  VanEck Biotech ETF

 Performance 
       Timeline  
Raytheon Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Raytheon Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Raytheon Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
VanEck Biotech ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

Raytheon Technologies and VanEck Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Raytheon Technologies and VanEck Biotech

The main advantage of trading using opposite Raytheon Technologies and VanEck Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Raytheon Technologies position performs unexpectedly, VanEck Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will offset losses from the drop in VanEck Biotech's long position.
The idea behind Raytheon Technologies and VanEck Biotech ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world